- Novo Nordisk signed a deal to acquire Irish biotech Prothena’s experimental anti-amyloid heart drug and broader amyloidosis program.
- Eli Lilly acquired Protomer Technologies, a biotech that engineers peptides and proteins.
- GlaxoSmithKline signed a deal with iTeos Therapeutics to co-develop and co-commercialize its experimental monoclonal antibody cancer treatment.
- Merck signed a deal with the U.S. government under which it will receive $1.2 billion for 1.7 million courses of its COVID-19 antiviral drug molnupiravir if it’s FDA-authorized.
- Walgreens sold its wholesaling arm, Alliance Healthcare, to AmerisourceBergen for $6.5 billion.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
